Stockreport

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF ? Q4 2025 Net Revenue of $128.6 million ? ? Pro Forma Full Year 2025 Net Revenue of $401.3 million ?   ? Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 [Read more]